Abstract
We investigated three SARS-CoV-2 variant B.1.1.7 kindergarten outbreaks and related household situations. Despite group cohorting, cases occurred in almost all groups, i.e. also among persons without close contact. Secondary attack rates (SAR) of children were similar to adults (day care: 23% vs. 30%; p=0.15; households: 32% vs. 39%; p=0.27), and also child-induced household outbreaks led to similar SAR compared to adults. With the advent of B.1.1.7, susceptibility and infectiousness of children and adults seem to converge.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received, that should be reported.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The German Protection against Infection Act and the law on the duties of the Robert Koch Institute (RKI) allowed the implementation of this outbreak investigation without seeking further institutional ethical review (Infektionsschutzgesetz, IfSG, BGBl. I S. 1045 https://www.rki.de/DE/Content/Infekt/IfSG/ifsg_node.html; https://www.gesetze-im-internet.de/ifsg/index.html). Informed consent was obtained from participants. As deputy head of the Department for Infectious Disease Epidemiology at the RKI, the national Public Health Institute of Germany, certified that: - She is the competent authority for assessing whether outbreak investigations and/or research require review by an institutional ethics committee or if the German Protection against Infection Act (Infektionsschutzgesetz, IfSG, BGBl. I S. 1045) allows investigation and/or research without additional institutional review. - The outbreak investigation presented by Loenenbach & Markus et al. in 'Susceptibility and infectiousness of children and adults with SARS-CoV-2 variant B.1.1.7 deduced from three daycare centre outbreaks and related household situations; Germany, 2021' was conducted as part of the official tasks of the local public health authorities of the respective district, supported by the RKI upon official request in accordance to paragraph 4 of the German Protection against Infection Act. Therefore, this investigation was exempt from additional institutional review. We are happy to provide a signed letter with this declaration. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.